Telmisartan

Category: pharmacological

Aliases: Micardis

Pharmacological Mechanism

AT1 receptor blocker + partial PPAR-γ agonist — unique among ARBs in modest insulin-sensitizing activity. Long half-life supports once-daily dosing. Research interest as a longevity / metabolic compound goes beyond standard ARB use.

Half-Life (t½)

PO: 24h

Dosing Guidelines

• PO: Typical 40mg (Range: 20 - 80 mg)

Target Organ Systems

• cardiovascular
• endocrine